(Q49156929)

18 February 2018

title

Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study. (English)

1 reference

18 February 2018

0 references

O L Pedersen

1

1 reference

18 February 2018

P Kragh-Sørensen

2

1 reference

18 February 2018

M Bjerre

3

1 reference

18 February 2018

K F Overø

4

1 reference

18 February 2018

L F Gram

5

1 reference

18 February 2018

publication date

1 January 1982

1 reference

18 February 2018

number of pages

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

18 February 2018

volume

77

1 reference

18 February 2018

issue

3

1 reference

18 February 2018

page(s)

199-204

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00464566

exact match

0 references

cites work

The efficacy of antidepressant drugs. A review of research (1958-1972).

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00464566

AMINE UPTAKE INHIBITORS: CRITERIA OF SELECTIVITY

21 January 2018

1 reference

12 December 2020

Plasma-nortriptyline levels in endogenous depression.

1 reference

12 December 2020

The kinetics of citalopram: single and multiple dose studies in man

1 reference

12 December 2020

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

1 reference

12 December 2020

Correlation of Subjective Side Effects with Plasma Concentrations of Nortriptyline

1 reference

12 December 2020

Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure disch

1 reference

12 December 2020

Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels

1 reference

12 December 2020

Steady-state kinetics of imipramine in patients

1 reference

12 December 2020

Effect of a selective 5-HT uptake inhibitor--Lu 10-171--on rat brain 5-HT turnover

1 reference

12 December 2020

Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro

1 reference

12 December 2020

Studies on acute toxicity and drug levels of citalopram in the dog

1 reference

12 December 2020

Preliminary studies of the kinetics of citalopram in man

1 reference

12 December 2020

Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline

1 reference

12 December 2020

Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties

1 reference

12 December 2020

International reliability and communicability of a rating scale for depression

1 reference

12 December 2020

Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses. II

1 reference

12 December 2020

Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171

1 reference

12 December 2020

Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).

1 reference

12 December 2020

High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00464566

1 reference

18 February 2018

Dimensions Publication ID

1024313776

0 references

1 reference

18 February 2018